PubMed:10228155
Annnotations
PMID_GLOBAL
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 285-311 | DiseaseOrPhenotypicFeature | denotes | adenomatous polyposis coli | 0021055 |
| T2 | 318-323 | DiseaseOrPhenotypicFeature | denotes | tumor | 0005070 |
| T3 | 378-387 | DiseaseOrPhenotypicFeature | denotes | neoplasia | 0005070 |
| T4 | 1590-1595 | DiseaseOrPhenotypicFeature | denotes | tumor | 0005070 |
FSU-PRGE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 18-22 | protein | denotes | FWD1 |
| T2 | 33-42 | protein | denotes | ubiquitin |
| T3 | 68-80 | protein | denotes | beta-catenin |
| T4 | 82-94 | protein | denotes | beta-catenin |
| T5 | 126-134 | protein | denotes | Wingless |
| T6 | 135-138 | protein | denotes | Wnt |
| T7 | 183-191 | protein | denotes | cadherin |
| T8 | 231-243 | protein | denotes | beta-catenin |
| T9 | 285-311 | protein | denotes | adenomatous polyposis coli |
| T10 | 313-316 | protein | denotes | APC |
| T11 | 389-401 | protein | denotes | beta-catenin |
| T12 | 430-439 | protein | denotes | ubiquitin |
| T13 | 473-485 | protein | denotes | beta-catenin |
| T14 | 564-594 | protein | denotes | glycogen synthase kinase-3beta |
| T15 | 596-605 | protein | denotes | GSK-3beta |
| T16 | 607-611 | protein | denotes | Axin |
| T17 | 612-618 | protein | denotes | kinase |
| T18 | 646-650 | protein | denotes | FWD1 |
| T19 | 675-680 | protein | denotes | Slimb |
| T20 | 681-689 | protein | denotes | betaTrCP |
| T21 | 773-785 | protein | denotes | beta-catenin |
| T22 | 787-791 | protein | denotes | Axin |
| T23 | 793-802 | protein | denotes | GSK-3beta |
| T24 | 807-810 | protein | denotes | APC |
| T25 | 868-880 | protein | denotes | beta-catenin |
| T26 | 912-916 | protein | denotes | FWD1 |
| T27 | 918-922 | protein | denotes | FWD1 |
| T28 | 978-990 | protein | denotes | beta-catenin |
| T29 | 1025-1037 | protein | denotes | beta-catenin |
| T30 | 1094-1098 | protein | denotes | FWD1 |
| T31 | 1151-1163 | protein | denotes | beta-catenin |
| T32 | 1196-1200 | protein | denotes | Skp1 |
| T33 | 1201-1207 | protein | denotes | Cullin |
| T34 | 1222-1226 | protein | denotes | FWD1 |
| T35 | 1228-1235 | protein | denotes | SCFFWD1 |
| T36 | 1237-1253 | protein | denotes | ubiquitin ligase |
| T37 | 1277-1289 | protein | denotes | beta-catenin |
| T38 | 1314-1318 | protein | denotes | FWD1 |
| T39 | 1374-1386 | protein | denotes | beta-catenin |
| T40 | 1388-1392 | protein | denotes | FWD1 |
| T41 | 1441-1450 | protein | denotes | ubiquitin |
| T42 | 1516-1528 | protein | denotes | beta-catenin |
| T43 | 1562-1569 | protein | denotes | SCFFWD1 |
| T44 | 1646-1658 | protein | denotes | beta-catenin |
2015-BEL-Sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1046-1163 | cat(p(HGNC:BTRC)) increases deg(p(HGNC:CTNNB1)) | denotes | In contrast, a dominant-negative mutant form of FWD1 inhibited the ubiquitination process and stabilized beta-catenin |
2015-BEL-Sample-2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| BEL:20000066 | 1046-1163 | cat(p(HGNC:BTRC)) increases deg(p(HGNC:CTNNB1)) | denotes | In contrast, a dominant-negative mutant form of FWD1 inhibited the ubiquitination process and stabilized beta-catenin |
| BEL:20033576 | 473-626 | complex(p(HGNC:AXIN1),p(HGNC:GSK3B)) directlyIncreases kin(p(HGNC:GSK3B)) | denotes | beta-catenin ubiquitination is preceded by phosphorylation of its N-terminal region by the glycogen synthase kinase-3beta (GSK-3beta)/Axin kinase complex |
| BEL:20033604 | 918-1044 | complex(p(HGNC:BTRC),p(HGNC:CTNNB1)) directlyIncreases deg(p(HGNC:CTNNB1)) | denotes | FWD1 facilitated ubiquitination and promoted degradation of beta-catenin, resulting in reduced cytoplasmic beta-catenin levels |
| BEL:20034092 | 812-916 | complex(p(HGNC:SKP1),p(HGNC:CUL1),p(HGNC:FBXO5),p(HGNC:BTRC)) directlyIncreases complex(p(HGNC:BTRC),p(HGNC:CTNNB1)) | denotes | Mutations at the signal-induced phosphorylation site of beta-catenin inhibited its association with FWD1 |
| BEL:20040698 | 918-1044 | p(HGNC:BTRC) increases deg(p(HGNC:CTNNB1)) | denotes | FWD1 facilitated ubiquitination and promoted degradation of beta-catenin, resulting in reduced cytoplasmic beta-catenin levels |
| BEL:20041244 | 812-916 | p(HGNC:CTNNB1,pmod(P,S)) increases complex(p(HGNC:BTRC),p(HGNC:CTNNB1)) | denotes | Mutations at the signal-induced phosphorylation site of beta-catenin inhibited its association with FWD1 |
| BEL:20041246 | 473-626 | p(HGNC:CTNNB1,pmod(P,S)) directlyIncreases deg(p(HGNC:CTNNB1)) | denotes | beta-catenin ubiquitination is preceded by phosphorylation of its N-terminal region by the glycogen synthase kinase-3beta (GSK-3beta)/Axin kinase complex |
| BEL:20029422 | 1046-1163 | cat(p(HGNC:BTRC)) increases deg(p(HGNC:CTNNB1)) | denotes | In contrast, a dominant-negative mutant form of FWD1 inhibited the ubiquitination process and stabilized beta-catenin |
| BEL:20036696 | 473-626 | kin(p(HGNC:GSK3B)) directlyIncreases p(HGNC:CTNNB1,pmod(P,S)) | denotes | beta-catenin ubiquitination is preceded by phosphorylation of its N-terminal region by the glycogen synthase kinase-3beta (GSK-3beta)/Axin kinase complex |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 318-323 | HP_0002664 | denotes | tumor |
| T2 | 378-387 | HP_0002664 | denotes | neoplasia |
| T3 | 1590-1595 | HP_0002664 | denotes | tumor |